Jeffrey  Bolton net worth and biography

Jeffrey Bolton Biography and Net Worth

Director of Enhabit

Mr. Bolton brings over two decades of executive and board experience in the healthcare sector. His deep knowledge of acute care hospital operations, innovation in complex care for seniors and integrated health networks, and his combination of financial, digital health, strategic planning, business development, and operational expertise contribute to the Board’s oversight of Enhabit’s operating model and multi-faceted growth strategy.

What is Jeffrey Bolton's net worth?

The estimated net worth of Jeffrey Bolton is at least $915.00 thousand as of December 12th, 2024. Mr. Bolton owns 98,144 shares of Enhabit stock worth more than $914,997 as of December 5th. This net worth evaluation does not reflect any other investments that Mr. Bolton may own. Learn More about Jeffrey Bolton's net worth.

How do I contact Jeffrey Bolton?

The corporate mailing address for Mr. Bolton and other Enhabit executives is , , . Enhabit can also be reached via phone at 214-239-6500 and via email at [email protected]. Learn More on Jeffrey Bolton's contact information.

Has Jeffrey Bolton been buying or selling shares of Enhabit?

Jeffrey Bolton has not been actively trading shares of Enhabit during the last ninety days. Most recently, on Thursday, December 12th, Jeffrey Bolton bought 4,000 shares of Enhabit stock. The stock was acquired at an average cost of $8.69 per share, with a total value of $34,760.00. Following the completion of the transaction, the director now directly owns 98,144 shares of the company's stock, valued at $852,871.36. Learn More on Jeffrey Bolton's trading history.

Who are Enhabit's active insiders?

Enhabit's insider roster includes Jeffrey Bolton (Director), Erin Hoeflinger (Director), and Stuart McGuigan (Director). Learn More on Enhabit's active insiders.

Are insiders buying or selling shares of Enhabit?

During the last twelve months, Enhabit insiders bought shares 3 times. They purchased a total of 29,000 shares worth more than $243,310.00. During the last twelve months, insiders at the sold shares 1 times. They sold a total of 1,096 shares worth more than $9,403.68. The most recent insider tranaction occured on August, 8th when CFO Ryan Solomon bought 10,000 shares worth more than $76,400.00. Insiders at Enhabit own 3.4% of the company. Learn More about insider trades at Enhabit.

Information on this page was last updated on 8/8/2025.

Jeffrey Bolton Insider Trading History at Enhabit

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/12/2024Buy4,000$8.69$34,760.0098,144View SEC Filing Icon  
8/22/2024Buy5,000$8.01$40,050.0078,877View SEC Filing Icon  
5/17/2024Buy10,000$8.33$83,300.0052,299View SEC Filing Icon  
5/10/2024Buy10,000$8.24$82,400.0042,299View SEC Filing Icon  
5/26/2023Buy2,000$11.61$23,220.0019,597View SEC Filing Icon  
5/17/2023Buy2,000$11.80$23,600.0017,597View SEC Filing Icon  
11/18/2022Buy1,000$12.69$12,690.0015,597View SEC Filing Icon  
11/9/2022Buy2,000$12.75$25,500.0014,597View SEC Filing Icon  
See Full Table

Jeffrey Bolton Buying and Selling Activity at Enhabit

This chart shows Jeffrey Bolton's buying and selling at Enhabit by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Enhabit Company Overview

Enhabit logo
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.
Read More

Today's Range

Now: $9.32
Low: $9.19
High: $9.39

50 Day Range

MA: $8.34
Low: $7.68
High: $9.71

2 Week Range

Now: $9.32
Low: $6.47
High: $10.90

Volume

455,191 shs

Average Volume

588,822 shs

Market Capitalization

$471.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.67